Can you provide the last earnings date for XENETIC BIOSCIENCES INC?
XENETIC BIOSCIENCES INC (XBIO) last reported earnings on 3/16/2026.
NASDAQ:XBIO • US9840156023
Past quarterly earnings results for XENETIC BIOSCIENCES INC (XBIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.53 | - | 22.00% | 766.3K | 703.8K | 8.88% | 18.26% | |
| Q3 2025 | -0.50 | - | -78.50% | 1.027M | 642.6K | 59.82% | 67.20% | |
| Q2 2025 | -0.45 | -0.65 | 31.07% | 45.78% | 589.9K | 652.8K | -9.64% | -18.79% |
| Q1 2025 | -0.59 | -0.73 | 19.66% | 24.36% | 593.26K | 683.4K | -13.19% | 16.14% |
| Q4 2024 | -0.68 | -0.20 | -233.33% | 11.69% | 648K | 234.6K | 176.21% | -3.57% |
| Q3 2024 | -0.28 | -0.14 | -96.08% | 59.42% | 614.24K | 765K | -19.71% | 0.50% |
| Q2 2024 | -0.83 | -0.85 | 1.96% | -20.29% | 726.4K | 550.8K | 31.88% | 11.58% |
| Q1 2024 | -0.78 | -0.81 | 3.20% | -30.00% | 510.82K | 663K | -22.95% | -15.68% |
| Q4 2023 | -0.77 | -0.89 | 13.23% | 23.00% | 672K | 693.6K | -3.11% | 37.14% |
| Q3 2023 | -0.69 | -1.14 | 39.60% | -15.00% | 611.17K | 489.6K | 24.83% | 49.07% |
| Q2 2023 | -0.69 | -1.15 | 40.14% | 63.68% | 651.01K | 448.8K | 45.06% | 55.00% |
| Q1 2023 | -0.60 | -1.12 | 46.52% | 50.00% | 605.84K | 418.2K | 44.87% | 55.34% |
| Q4 2022 | -1.00 | -0.92 | -8.93% | -553.59% | 490K | 204K | 140.20% | 48.48% |
| Q3 2022 | -0.60 | -1.84 | 67.32% | 53.85% | 410K | 357K | 14.85% | 17.14% |
| Q2 2022 | -1.90 | -1.22 | -55.23% | -46.15% | 420K | 346.8K | 21.11% | 44.83% |
| Q1 2022 | -1.20 | -1.12 | -6.95% | 20.00% | 390K | 346.8K | 12.46% | 105.26% |
| Q4 2021 | -0.15 | - | 90.44% | 330K | 102K | 223.53% | 120.00% | |
| Q3 2021 | -1.30 | -1.22 | -6.21% | -148.15% | 350K | 204K | 71.57% | 191.67% |
| Q2 2021 | -1.30 | -1.63 | 20.34% | 13.33% | 290K | 193.8K | 49.64% | 163.64% |
| Q1 2021 | -1.50 | -1.33 | -13.12% | 21.05% | 190K | 61.2K | 210.46% | 216.67% |
| Q4 2020 | -1.60 | -2.04 | 21.57% | - | 150K | 121.89K | 23.06% | - |
| Q3 2020 | 2.70 | -1.58 | 270.78% | - | 120K | 98.94K | 21.29% | - |
| Q2 2020 | -1.50 | -2.24 | 33.16% | - | 110K | 61.2K | 79.74% | - |
| Q1 2020 | -1.90 | -3.77 | 49.66% | - | 60K | - | - |
Notes
XENETIC BIOSCIENCES INC (XBIO) last reported earnings on 3/16/2026.
XENETIC BIOSCIENCES INC (XBIO) missed EPS estimates and beat revenue estimates in the most recent quarter.